Estradiol treatment, physical activity, and muscle function in ovarian-senescent mice

Experimental Gerontology

Volumn 46, Issue 8, 2011, Pages 685-693

  Greising, Sarah M ^a   Carey, Ryan S ^a   Blackford, Jennifer E ^a   Dalton, Laurin E ^a   Kosir, Allison M ^a   Lowe, Dawn A ^a  

^a UNIVERSITY OF MINNESOTA MEDICAL SCHOOL   (United States)

Author keywords

4 Vinylcyclohexene diepoxide; Aging; Estrogen; Exercise; Skeletal muscle

Indexed keywords

4 VINYLCYCLOHEXENE DIEPOXIDE; EPOXIDE; ESTRADIOL; PLACEBO; UNCLASSIFIED DRUG;

AGED; AGING; ANIMAL BEHAVIOR; ANIMAL EXPERIMENT; ANIMAL TISSUE; ARTICLE; CONCENTRIC MUSCLE CONTRACTION; CONTROLLED STUDY; ECCENTRIC MUSCLE CONTRACTION; ESTRADIOL BLOOD LEVEL; ESTROGEN ACTIVITY; FEMALE; LOCOMOTION; MOUSE; MUSCLE FATIGUE; MUSCLE FORCE; MUSCLE FUNCTION; MUSCLE ISOMETRIC CONTRACTION; MUSCLE STRENGTH; MUSCLE TETANIC CONTRACTION; NONHUMAN; OVARIECTOMY; OVARY FOLLICLE; OVARY FUNCTION; PHYSICAL ACTIVITY; PRIORITY JOURNAL; RUNNING; SENESCENCE; SOLEUS MUSCLE; VAGINA CYTOLOGY;

AGING; ANIMALS; CYCLOHEXENES; ESTRADIOL; FEMALE; MICE; MICE, INBRED C57BL; MUSCLE FATIGUE; MUSCLE, SKELETAL; OVARIECTOMY; PHYSICAL CONDITIONING, ANIMAL; RANDOM ALLOCATION; VINYL COMPOUNDS;

MUS;

EID: 79960032355     PISSN: 05315565     EISSN: 18736815     Source Type: Journal    
DOI: 10.1016/j.exger.2011.04.006     Document Type: Article

References (58)

1. Acosta J.I., Mayer L., Talboom J.S., Tsang C.W., Smith C.J., Enders C.K., Bimonte-Nelson H.A. Transitional versus surgical menopause in a rodent model: etiology of ovarian hormone loss impacts memory and the acetylcholine system. Endocrinology 2009, 150:4248-4259.
2. NTP Toxicology and Carcinogenesis Studies of 4-Vinylcyclohexene (CAS No. 100-40-3) in F344/N Rats and B6C3F1 Mice (Gavage Studies), Natl Toxicol Program Tech Rep Ser 303 (1986) 1-190.
3. Toxicology and Carcinogenesis Studies of 4-Vinyl-1-cyclohexene Diepoxide (CAS No. 106-87-6) in F344/N Rats and B6C3F1 Mice (Dermal Studies), Natl Toxicol Program Tech Rep Ser 362 (1989) 1-249.
4. Baltgalvis K.A., Greising S.M., Warren G.L., Lowe D.A. Estrogen regulates estrogen receptors and antioxidant gene expression in mouse skeletal muscle. PLoS One 2010, 5:e10164.
5. Brooks S.V., Faulkner J.A. Contractile properties of skeletal muscles from young, adult and aged mice. J. Physiol. 1988, 404:71-82.
6. Danilovich N., Ram Sairam M. Recent female mouse models displaying advanced reproductive aging. Exp. Gerontol. 2006, 41:117-122.
7. Fahrbach S.E., Meisel R.L., Pfaff D.W. Preoptic implants of estradiol increase wheel running but not the open field activity of female rats. Physiol. Behav. 1985, 35:985-992.
8. Fan W., Yanase T., Nomura M., Okabe T., Goto K., Sato T., Kawano H., Kato S., Nawata H. Androgen receptor null male mice develop late-onset obesity caused by decreased energy expenditure and lipolytic activity but show normal insulin sensitivity with high adiponectin secretion. Diabetes 2005, 54:1000-1008.
9. Foster T.C. Interaction of rapid signal transduction cascades and gene expression in mediating estrogen effects on memory over the life span. Front. Neuroendocrinol. 2005, 26:51-64.
10. Going S., Lohman T., Houtkooper L., Metcalfe L., Flint-Wagner H., Blew R., Stanford V., Cussler E., Martin J., Teixeira P., Harris M., Milliken L., Figueroa-Galvez A., Weber J. Effects of exercise on bone mineral density in calcium-replete postmenopausal women with and without hormone replacement therapy. Osteoporos. Int. 2003, 14:637-643.
11. Golub M.S., Germann S.L., Mercer M., Gordon M.N., Morgan D.G., Mayer L.P., Hoyer P.B. Behavioral consequences of ovarian atrophy and estrogen replacement in the APPswe mouse. Neurobiol. Aging 2008, 29:1512-1523.
12. Gorzek J.F., Hendrickson K.C., Forstner J.P., Rixen J.L., Moran A.L., Lowe D.A. Estradiol and tamoxifen reverse ovariectomy-induced physical inactivity in mice. Med. Sci. Sports Exerc. 2007, 39:248-256.
13. Greising S.M., Landisch R.M., Song E.S., Lowe D.A. Effects of estrogen replacement on skeletal muscle of aged mice that experienced natural ovarian-failure. Med. Sci. Sports Exerc. 2008, 40:S350.
14. Greising S.M., Baltgalvis K.A., Lowe D.A., Warren G.L. Hormone therapy and skeletal muscle strength: a meta-analysis. J. Gerontol. A Biol. Sci. Med. Sci. 2009, 64:1071-1081.
15. Greising S.M., Baltgalvis K.A., Kosir A.M., Moran A.L., Warren G.L., Lowe D.A. Estradiol's beneficial effect on murine muscle function is independent of muscle activity. J. Appl. Physiol. 2011, 110:109-115.
16. Heikkinen T., Kalesnykas G., Rissanen A., Tapiola T., Iivonen S., Wang J., Chaudhuri J., Tanila H., Miettinen R., Puolivali J. Estrogen treatment improves spatial learning in APP+PS1 mice but does not affect beta amyloid accumulation and plaque formation. Exp. Neurol. 2004, 187:105-117.
17. Hertrampf T., Seibel J., Laudenbach U., Fritzemeier K.H., Diel P. Analysis of the effects of oestrogen receptor alpha (ERalpha)- and ERbeta-selective ligands given in combination to ovariectomized rats. Br. J. Pharmacol. 2008, 153:1432-1437.
18. Hicks A.L., Kent-Braun J., Ditor D.S. Sex differences in human skeletal muscle fatigue. Exerc. Sport Sci. Rev. 2001, 29:109-112.
19. Hoyer P.B., Devine P.J., Hu X., Thompson K.E., Sipes I.G. Ovarian toxicity of 4-vinylcyclohexene diepoxide: a mechanistic model. Toxicol. Pathol. 2001, 29:91-99.
20. Hu X., Christian P.J., Thompson K.E., Sipes I.G., Hoyer P.B. Apoptosis induced in rats by 4-vinylcyclohexene diepoxide is associated with activation of the caspase cascades. Biol. Reprod. 2001, 65:87-93.
21. Hu X., Christian P., Sipes I.G., Hoyer P.B. Expression and redistribution of cellular Bad, Bax, and Bcl-X(L) protein is associated with VCD-induced ovotoxicity in rats. Biol. Reprod. 2001, 65:1489-1495.
22. Hu X., Flaws J.A., Sipes I.G., Hoyer P.B. Activation of mitogen-activated protein kinases and AP-1 transcription factor in ovotoxicity induced by 4-vinylcyclohexene diepoxide in rats. Biol. Reprod. 2002, 67:718-724.
23. Ingram D.K. Age-related decline in physical activity: generalization to nonhumans. Med. Sci. Sports Exerc. 2000, 32:1623-1629.
24. Kadi F., Karlsson C., Larsson B., Eriksson J., Larval M., Billig H., Jonsdottir I.H. The effects of physical activity and estrogen treatment on rat fast and slow skeletal muscles following ovariectomy. J. Muscle Res. Cell Motil. 2002, 23:335-339.
25. Kotz C.M., Teske J.A., Levine J.A., Wang C. Feeding and activity induced by orexin A in the lateral hypothalamus in rats. Regul. Pept. 2002, 104:27-32.
26. Landisch R.M., Kosir A.M., Nelson S.A., Baltgalvis K.A., Lowe D.A. Adaptive and nonadaptive responses to voluntary wheel running by mdx mice. Muscle Nerve 2008, 38:1290-1303.
27. Levin-Allerhand J.A., Sokol K., Smith J.D. Safe and effective method for chronic 17beta-estradiol administration to mice. Contemp. Top. Lab. Anim. Sci. 2003, 42:33-35.
28. Lightfoot J.T. Sex hormones' regulation of rodent physical activity: a review. Int. J. Biol. Sci. 2008, 4:126-132.
29. Lohff J.C., Christian P.J., Marion S.L., Hoyer P.B. Effect of duration of dosing on onset of ovarian failure in a chemical-induced mouse model of perimenopause. Menopause 2006, 13:482-488.
30. Lowe D.A., Baltgalvis K.A., Greising S.M. Mechanisms behind estrogen's beneficial effect on muscle strength in females. Exerc. Sport Sci. Rev. 2010, 38:61-67.
31. MacLean H.E., Chiu W.S., Notini A.J., Axell A.M., Davey R.A., McManus J.F., Ma C., Plant D.R., Lynch G.S., Zajac J.D. Impaired skeletal muscle development and function in male, but not female, genomic androgen receptor knockout mice. FASEB J. 2008, 22:2676-2689.
32. Maddalozzo G.F., Widrick J.J., Cardinal B.J., Winters-Stone K.M., Hoffman M.A., Snow C.M. The effects of hormone replacement therapy and resistance training on spine bone mineral density in early postmenopausal women. Bone 2007, 40:1244-1251.
33. Mayer L.P., Pearsall N.A., Christian P.J., Devine P.J., Payne C.M., McCuskey M.K., Marion S.L., Sipes I.G., Hoyer P.B. Long-term effects of ovarian follicular depletion in rats by 4-vinylcyclohexene diepoxide. Reprod. Toxicol 2002, 16:775-781.
34. Mayer L.P., Devine P.J., Dyer C.A., Hoyer P.B. The follicle-deplete mouse ovary produces androgen. Biol. Reprod. 2004, 71:130-138.
35. McCully K.K., Faulkner J.A. Characteristics of lengthening contractions associated with injury to skeletal muscle fibers. J. Appl. Physiol. 1986, 61:293-299.
36. Moran A.L., Warren G.L., Lowe D.A. Soleus and EDL muscle contractility across the lifespan of female C57BL/6 mice. Exp. Gerontol. 2005, 40:966-975.
37. Moran A.L., Warren G.L., Lowe D.A. Removal of ovarian hormones from mature mice detrimentally affects muscle contractile function and myosin structural distribution. J. Appl. Physiol. 2006, 100:548-559.
38. Moran A.L., Nelson S.A., Landisch R.M., Warren G.L., Lowe D.A. Estradiol replacement reverses ovariectomy-induced muscle contractile and myosin dysfunction in mature female mice. J. Appl. Physiol. 2007, 102:1387-1393.
39. Morgan M.A., Pfaff D.W. Effects of estrogen on activity and fear-related behaviors in mice. Horm. Behav. 2001, 40:472-482.
40. Nelson J.F., Felicio L.S., Osterburg H.H., Finch C.E. Altered profiles of estradiol and progesterone associated with prolonged estrous cycles and persistent vaginal cornification in aging C57BL/6 J mice. Biol. Reprod. 1981, 24:784-794.
41. Nelson J.F., Felicio L.S., Randall P.K., Sims C., Finch C.E. A longitudinal study of estrous cyclicity in aging C57BL/6J mice: I. Cycle frequency, length and vaginal cytology. Biol. Reprod. 1982, 27:327-339.
42. Nelson J.F., Bergman M.D., Karelus K., Felicio L.S. Aging of the hypothalamo-pituitary-ovarian axis: hormonal influences and cellular mechanisms. J. Steroid Biochem. 1987, 27:699-705.
43. Ogawa S., Chan J., Gustafsson J.A., Korach K.S., Pfaff D.W. Estrogen increases locomotor activity in mice through estrogen receptor alpha: specificity for the type of activity. Endocrinology 2003, 144:230-239.
44. Ophoff J., Callewaert F., Venken K., De Gendt K., Ohlsson C., Gayan-Ramirez G., Decramer M., Boonen S., Bouillon R., Verhoeven G., Vanderschueren D. Physical activity in the androgen receptor knockout mouse: evidence for reversal of androgen deficiency on cancellous bone. Biochem. Biophys. Res. Commun. 2009, 378:139-144.
45. Phillips S.K., Rook K.M., Siddle N.C., Bruce S.A., Woledge R.C. Muscle weakness in women occurs at an earlier age than in men, but strength is preserved by hormone replacement therapy. Clin. Sci. (Lond.) 1993, 84:95-98.
46. Ribeiro A.C., Pfaff D.W., Devidze N. Estradiol modulates behavioral arousal and induces changes in gene expression profiles in brain regions involved in the control of vigilance. Eur. J. Neurosci. 2009, 29:795-801.
47. Rivera Z., Christian P.J., Marion S.L., Brooks H.L., Hoyer P.B. Steroidogenic capacity of residual ovarian tissue in 4-vinylcyclohexene diepoxide-treated mice. Biol. Reprod. 2009, 80:328-336.
48. Sipila S., Taaffe D.R., Cheng S., Puolakka J., Toivanen J., Suominen H. Effects of hormone replacement therapy and high-impact physical exercise on skeletal muscle in post-menopausal women: a randomized placebo-controlled study. Clin. Sci. (Lond.) 2001, 101:147-157.
49. Springer L.N., McAsey M.E., Flaws J.A., Tilly J.L., Sipes I.G., Hoyer P.B. Involvement of apoptosis in 4-vinylcyclohexene diepoxide-induced ovotoxicity in rats. Toxicol. Appl. Pharmacol. 1996, 139:394-401.
50. Stranahan A.M., Lee K., Mattson M.P. Contributions of impaired hippocampal plasticity and neurodegeneration to age-related deficits in hormonal pulsatility. Ageing Res. Rev. 2008, 7:164-176.
51. Suzuki S., Brown C.M., Dela Cruz C.D., Yang E., Bridwell D.A., Wise P.M. Timing of estrogen therapy after ovariectomy dictates the efficacy of its neuroprotective and antiinflammatory actions. Proc. Natl. Acad. Sci. U. S. A. 2007, 104:6013-6018.
52. Taaffe D.R., Sipila S., Cheng S., Puolakka J., Toivanen J., Suominen H. The effect of hormone replacement therapy and/or exercise on skeletal muscle attenuation in postmenopausal women: a yearlong intervention. Clin. Physiol. Funct. Imaging 2005, 25:297-304.
53. Teixeira P.J., Going S.B., Houtkooper L.B., Metcalfe L.L., Blew R.M., Flint-Wagner H.G., Cussler E.C., Sardinha L.B., Lohman T.G. Resistance training in postmenopausal women with and without hormone therapy. Med. Sci. Sports Exerc. 2003, 35:555-562.
54. Warren G.L., Hayes D.A., Lowe D.A., Williams J.H., Armstrong R.B. Eccentric contraction-induced injury in normal and hindlimb-suspended mouse soleus and EDL muscles. J. Appl. Physiol. 1994, 77:1421-1430.
55. Warren G.L., Moran A.L., Hogan H.A., Lin A.S., Guldberg R.E., Lowe D.A. Voluntary run training but not estradiol deficiency alters the tibial bone-soleus muscle functional relationship in mice. Am. J. Physiol. Regul. Integr. Comp. Physiol. 2007, 293:R2015-R2026.
56. Wiik A., Ekman M., Johansson O., Jansson E., Esbjornsson M. Expression of both oestrogen receptor alpha and beta in human skeletal muscle tissue. Histochem. Cell Biol. 2009, 131:181-189.
57. Wineinger M.A., Abresch R.T., Walsh S.A., Carter G.T. Effects of aging and voluntary exercise on the function of dystrophic muscle from mdx mice. Am. J. Phys. Med. Rehabil. 1998, 77:20-27.
58. Wu J.M., Zelinski M.B., Ingram D.K., Ottinger M.A. Ovarian aging and menopause: current theories, hypotheses, and research models. Exp. Biol. Med. (Maywood) 2005, 230:818-828.